Sphingosine 1-phosphate and control of vascular tone

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Dantas, Ana Paula V ^a   Igarashi, Junsuke ^a,c   Michel, Thomas ^a,b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c KAGAWA UNIVERSITY   (Japan)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endothelial nitric oxide synthase phosphorylation; Endothelium dependent relaxation; Nitric oxide; Sphingolipids

Indexed keywords

4 AMINOPYRIDINE; CALCIUM; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; SERINE; SPHINGOSINE 1 PHOSPHATE; WORTMANNIN;

ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL TONE; CELL INTERACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 0038782021     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01089.2002     Document Type: Article

References (32)

1. Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdorf D, Jakobs KH, and Michel MC. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 130: 1871-1877, 2000.
2. Bischoff A, Finger J, and Michel MC. Nifedipine inhibits sphinogosine-1-phosphate-induced renovascular contraction in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol 364: 179-182, 2001.
3. 2+ and nitric oxide in bradykinin-stimulated vascular endothelial cells. Circ Res 76: 922-924, 1995.
4. Coroneos E, Martinez M, McKenna S, and Kester M. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J Biol Chem 270: 23305-23309, 1995.
5. 2+independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res 82: 686-695, 1998.
6. 2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88: E68-E75, 2001.
7. Goetz RM, Thatte HS, Prabhakar P, Cho MR, Michel T, and Golan DE. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 96: 2788-2793, 1999.
8. 2+ sensitivity as a key mechanism of PKC-induced constriction in pressurized cerebral arteries. Am J Physiol Heart Circ Physiol 277: H1178-H1188, 1999.
9. Goodemote KA, Mattie ME, Berger A, and Spiegel S. Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J Biol Chem 270: 10272-10277, 1995.
10. Harris MB, Hong JH, Venema VJ, Liang H, Zou R, Michell BJ, Chen Z, Kemp BE, and Venema RC. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 276: 16587-16591, 2001.
11. Hla T. Sphingosine 1-phosphate receptors. Prostaglandins 64: 135-142, 2001.
12. Hood JD, Meininger CJ, Ziche M, and Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol Heart Circ Physiol 274: H1054-H1058, 1998.
13. Igarashi J, Bernier SG, and Michel T. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem 276: 12420-12426, 2001.
14. Igarashi J and Michel T. Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase: evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways. J Biol Chem 276: 36281-36288, 2001.
15. Kou R, Greif D, and Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 277: 29669-29673, 2002.
16. Kowaluk EA, Seth P, and Fung HL. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 262: 916-922, 1992.
17. Kwon YG, Min JK, Kim KM, Lee DJ, Billiar TR, and Kim YM. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem 276: 10627-10633, 2001.
18. Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, and Hla T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279: 1552-1555, 1998.
19. Levade T, Augé N, Veldman RJ, Cuvillier O, Nègre-Salvayre A, and Salvayre R. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ Res 89: 957-968, 2001.
20. Loscalzo J and Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38: 87-104, 1995.
21. Marie I and Beny J. Calcium imaging of murine thoracic aorta endothelium by confocal microscopy reveals inhomogeneous distribution of endothelial cells responding to vasodilator agents. J Vasc Res 39: 260-267, 2002.
22. 1 receptors and the cardiovascular system: regulation of expression and function. Cardiovasc Res 48: 194-210, 2000.
23. i protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 276: 19672-19677, 2001.
24. Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, Ui M, and Okajima F. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352: 809-815, 2000.
25. Olivera A and Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365: 557-560, 1993.
26. Prabhakar P, Thatte HS, Goetz RM, Cho MR, Golan DE, and Michel T. Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem 273: 27383-27388, 1998.
27. Richard V, Tanner FC, Tschudi M, and Luscher TF. Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol Heart Circ Physiol 259: H1433-H1439, 1990.
28. Rikitake Y, Hirata K, Kawashima S, Ozaki M, Takahashi T, Ogawa W, Inoue N, and Yokoyama M. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler Thromb Vasc Biol 22: 108-114, 2002.
29. Rubanyi GM, Romero JC, and Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H1145-H1149, 1986.
30. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y, and Kume S. Distribution of sphingosine 1-phosphate, a bioactive sphingolipid, in rat tissues. J Biochem (Tokyo) 121: 969-973, 1997.
31. Yatomi Y, Ruan F, Hakomori SI, and Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86: 193-202, 1995.
32. Zygmunt PM and Hogestatt ED. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br J Pharmacol 117: 1600-1606, 1996.